Blood pressure targets for hypertension in older adults

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 3, 2015, Pages

  Garrison, Scott R ^a   Kolber, Michael R ^a   Korownyk, Christina S ^a   Mccracken, Rita K ^b   Allan, G Michael ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ALL CAUSE MORTALITY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; HOSPITALIZATION; HUMAN; HYPERTENSION; INSTITUTIONALIZATION; META ANALYSIS; MORTALITY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 85042038726     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011575     Document Type: Article

References (19)

1. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011;123(21):2434-506.
2. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. New England Journal of Medicine 2008 May 1;358(18):1887-98.
3. Cadieux RJ. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgraduate Medicine 1989 Dec;86(8):179-86.
4. Chan BT, Schultz SE. Supply and utilization of general practitioner and family physician services in Ontario. ICES investigative report. Toronto, ON: Institute for Clinical Evaluative Sciences www.ices.on.ca/file/FP-GP_aug08_FINAL.pdf. Toronto, ON, Aug 2005; Vol. Accessed Nov 12 2013.
5. Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, et al. Canadian Hypertension Education Program. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Canadian Journal of Cardiology May 2012;28(3):270-87.
6. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available from www.cochrane-handbook.org, (updated March 2011).
7. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundamental & Clinical Pharmacology 2007;21(3):217-30.
8. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertension Research 2008 Dec;31(12):2115-27.
9. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360(9349):1903-13.
10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. [DOI: http://dx.doi.org/10.1136/bmj.b2700]
11. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Pressure 2009;18(6):308-47.
12. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, et al. Most hospitalized older persons do not meet the enrolment criteria for clinical trials in heart failure. American Heart Journal 2003;146(2):250-7.
13. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD000028.pub2]
14. Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Archives of Internal Medicine 2012;172(15):1162-8.
15. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010 Aug;56(2):196-202.
16. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
17. Sabayan B, Oleksik AM, Maier AB, van Buchem MA, Poortvliet RK, de Ruijter W, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. Journal of the American Geriatric Society 2012;60(11):2014-9.
18. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007;297(11):1233-40.
19. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2]